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Abstract.Bronchoalveolar lavage is essential in evaluating airway’s status and 
response to treatment in horses with recurrent airway obstruction. In this study we 
investigated the changes of bronchoalveolar lavage (BAL) fluid in horses with recurrent 
airway obstruction undergoing treatment with corticosteroids. Cytologic examination revealed 
decreased neutrophils percentage in BAL fluid obtained from horses with recurrent airway 
obstruction at 21 days of treatment after receiving dexamethasone, compared with initial 
results before treatment. Cytologic examination of BAL fluid provided important data 
regarding the local inflammatory status of the airways before and after treatment. 
 




Recurrent airway obstruction (RAO) is a disease characterized by airway 
inflammation, bronchoconstriction and chronic obstruction of the airways [8]. Local airway 
inflammation, for both upper and lower airways, and pulmonary inflammation, is assessed by 
performing special diagnostic techniques like endoscopy, transtracheal aspiration (TTA),  
bronchoalveolar lavage (BAL) or pulmonary function testing [5, 6, 7]. The neutrophilic 
inflammation of the lower airways and the pathological changes of lungs in RAO affected 
horses, correlates with the results offered by cytological examination of BAL fluid [8]. These 
techniques are highly necessary because early diagnosis of the disease folowed by a rigurous 
treatment with corticosteroids, the use of bronchodilators and environmental management [1], 
will help the horse to have a satisfying sport performance [8].  
 
MATERIAL AND METHOD 
 
This study was conducted on 8 horses with recurrent airway obstruction (RAO). 
The horses, males and females were of different breeds, or cross bred, with ages 
between 7 and 16 years old. In all cases history was taken, horses were clinicaly examinated 
and in some of them a hiperventilation plastic bag was used or underwent mild physical 
exercise to intensify respiratory sounds. 
All horses were investigated by bronchoalveolar lavage on day 1, folowed by 
treatment with dexamethasone, and another bronchoalveolar lavage at the end of treatment, on 
day 21. 
 Bronchoalveolar lavage blind technique was performed in the standing horse using a 
special silicone BAL catheter, under mild sedation. Detomidine and butorphanol was used to 
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sedate the horses, and a twich was aplied on the horse’s upper lipp to minimise movement of 
the horse.  
The sample was collected using 300-500 ml of sterile saline solution. After collection, 
it was macroscopically examinated to evaluate the color, transparency and the presence of 
flocculent debris. 
Floculent samples were filtrated through two layers of gauze to remove excess mucus 
strands and other debris. The samples were processed by centrifugation for 5 minutes at 1,000 
RPM. For cytological interpretation direct smears were prepared from the sediment, after the 
supernatant was removed, and stained using Dia Quick Panoptic (DQP) or Diff Quick stains. 
From each sample about 3-5 smears were prepared and stained. Cytological interpretation was 
based on the percentage of each cellular population from the BAL sample. This was 
determined by differential cell counting of 300 consecutive cells in order to obtain an accurate 
representation of the cell types present, under oil immersion (1,000 X) in order to assure the 
specific morphology of each cell [4]. 
The treatment was performed by daily intravenous administration of 0.1 mg 
dexamethasone /kg body weight for the first 7 days, than the dose was reduced to 0.05 mg/kg 
body weight for the next 7 days, and the last week of treatment the horses received only 4 
intravenous injection at 48 hours intervals of 0.05 mg/kg body weight. During the 21 days of 
treatment all horses received soaked hay, and were stabled on a dust free bedding. 
Results were analyzed for normality of distribution using the Shapiro–Wilk normality 
test. The majority of data sets were found to be normally distributed. Mean comparison was 
done with the Anova; a confidence level of 95% (P<0.05) was considered significant. The R 
free software package was used for all the statistical analyses (R Development Core Team, 
2010). 
 
RESULTS AND DISCUSIONS 
 
Initial clinical examination of all RAO affected horses revealed increased respiratory 
efforts, cough, abnormal respiratory sounds, weezing and crackels due to increased mucus 
quantities within airways. History revealed that the horses had access to moldy straw during 
the last 3 months prior to sampling and in some of them the simptoms became evident when 
the concentration of pollen in the environment was higher that usual in the spring. At 7 days 
after receiving dexamethasone, clinical signs improved differently in horses with RAO and at 
the end of treatment, all horses showed no clinical signs of RAO, but still some of them 
revealed a mild respiratory discomfort when physicaly exercised. 
The volumes of BAL fluid samples obtained was between 30 to 80 ml per sample. 
Macroscopic examination of the BAL fluid, revealed various amounts of mucus and floculent 
material in samples from RAO affected horses before treatment. At the end of treatment the 
samples contained a clear or mild turbit fluid in RAO treated horses. Some samples had a 
mild pink color of the fluid retreived at the end of the lavage, and after the centrifugation, a 
small quantity of erythrocytes was noticed in the sediment. 
Dia Quick Panoptic (DQP) and Diff Quick staining allowed a quick evaluation of the 
cellular population in the sample, being a fast technique which makes it very useful in a 
clinician’s work (a total of 70 seconds).  
Total nucleated cell number in the BAL fluid was not evaluated because according to 
Hewson and Viel (2002), only an estimated cell count can be obtained if saline solution is 
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Table 1. 
Results (mean ± SD) of cytological examination of  BAL fluid obtained from 
RAO affected horses before treatment (RAO, day 1) and after treatment (RAO, 

































0.75±0.71 1.750.71 6.13±1.13 
*** 
 
The higher percentage of neutrophils (77.38 ± 3.85 %) in samples from horses with 
RAO before treatment compared with 5 – 30 %  in healthy horses, according to data provided 
by Hewson and Viel (2002), reveals a local inflammation, and confirms the inflammatory 
features of this disease. The value of neutrophils percentage found at the end of treatment 
(35.13±3.04) is close to values found in healthy horses according to data provided by 
Hewson and Viel (2002), and the difference is extremely significant (P<0.001) compared 


































Figure 1. Neutrophils percentage in BAL fluid from horses on day 1 before treatment (RAO1) 
is extremely significantly higher than at the end of treatment, on day 21 (RAO21). 
 
The percentage of macrophages was extremely significantly lower (P<0.001) after 
treatment. Cytology revealed in some horses the presence of macrophages containing 
erytrocytes and also in other horses fungal spores, hyphae or polen. The presence of fungal 
spores and hyphae in the macrophage’s cytoplasm does not indicate that the pacients had 
fungal pneumonia. This was correlated with moldy straw exposure prior to sampling. 
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The presence of erytrocytes in BAL fluid observed in some horses was correlated with 
possible bleeding associated with the procedure, especially when movement of the head and 
tube induced lesions of the small airways mucosa. Erytrophagocytosis is not patognomonic 
for effort induced pulmonary hemorrage, and can be seen if fresh blood was present in the 
airways. Also if the sample contains erytrocytes secondary to bleeding associated with the 
procedure, viabile macrophages from the BAL fluid can engulf the cells if the slides are not 






























Figure 2. Macrophages percentage in BAL fluid from horses on day 1 before treatment 
(RAO1) is extremely significantly lower than at the end of treatment, on day 21 (RAO21) 
 
Lymphocytes were found in a higher percentage after treatment compared with initial 
results, and the difference is extremely significant  (P<0.001). 
  































Figure 3. Lymphocytes percentage in BAL fluid from horses on day 1 before treatment 
(RAO1) is extremely significantly lower than at the end of treatment, on day 21 (RAO21). 
 
No significant difference was found regarding the percentage of eosinophils and mast 
cells between the results before and after treatment. The low percentage of eosinophils in 
BAL samples from horses with RAO confirms the fact that this disease is not always 
associated with a specific allergy after the onset of the disease, though in some horses, 
macrophages containing polen were noticed. 
There was an extremely significant difference (P<0.001) between epithelial cells 
percentage from initial results before treatment and epithelial cells percentage after treatment, 
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Figure 4. Epithelial cells percentage in BAL fluid from horses on day 1 before treatment 
(RAO1) is significantly lower than at the end of treatment, on day 21 (RAO21). 
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CONCLUSIONS 
 
 The increased neutrophils percentage in BAL fluid from RAO horses confirms a local 
inflammatory process.  
 Dexamethasone reduces local inflammation of the airways, wich is proved by the value of 
the neutrophils percentage in BAL fluid at the end of treatment. 
 The presence of fungal spores and hiphae fagocytosed by macrophages does not indicate a 
mycotic airway disorder, but offers valuable data regarding the horse’s management and 
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